Search

Author/Creator Nos, P

21. P457 Influence of concomitant immunomodulators during maintenance therapy with Adalimumab in inflammatory bowel disease: looking for the ideal patient to use monotherapy. (25th January 2019)

Authors:
Bastida, G; Bosó, V; Aguas, M; Bejar, S; Garrido, A; Iborra, M; del Hoyo, J; Tortosa, L; Muñoz, D; Marqués, R; Poveda, J L; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S340
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

22. P500 Real life 2 year experience with ustekinumab in a Spanish open-label cohort of ulcerative colitis patients. (30th January 2023)

Authors:
Iborra Colomino, M I; Ferreiro-Iglesias, R; Martín-Arranz, M D; Mesonero-Gismero, F; Mínguez, A; Porto Silva, S; García-Ramírez, L; García de la Filia, I; Bastida, G; Nieto García, L; Suárez Ferrer, C; Aguas, M; Barreiro de Acosta, M; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i629
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

23. P505 Real-world short-term effectiveness of ustekinumab in Crohn's disease: Results from the ENEIDA Registry. (25th January 2019)

Authors:
Iborra, M; Beltrán, B; Fernández, A; Gutiérrez, A; Antolín, B; Huguet, J M; de Francisco, R; Merino, O; Carpio, D; García López, S; Mesonero, F; Mínguez, M; Ferreiro, R; Carbajo, A Y; Rivero, M; Chaparro, M; Piñero-Pérez, M C; Monfort i Miquel, D; Bujanda, L; García-Sepulcre, M F
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S364
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

25. P559 Real-life experience with long-term maintenance of golimumab in ulcerative colitis patients. (25th January 2019)

Authors:
Iborra, M; García-Morales, N; Rubio, S; Nantes Castillejo, O; Bertoletti, F; García-Planella, E; Calvo, M; Vera, I; Taxonera, C; Alba, C; Boscá-Watts, M; Martí-Aguado, D; Ballester Ferrer, M P; Sierra, M; Cano-Sanz, N; Mancenido, N; Pajares-Villarroya, R; Beltrán, B; Cañada, A; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 13(2019)Supplement 1
Page Start:
S393
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

26. P576 Ustekinumab levels correlate with induction fecal calprotectin drop-slope and discriminate the need for intensification at week 52 in Crohn's Disease patients. (27th May 2021)

Authors:
Mateos, B; Sáez-González, E; Iborra, M; Moret, I; Cañada, A; Tortosa, L; Bastida, G; Aguas, M; Cerrillo, E; Nos, P; Beltrán, B
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S533
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

27. P634 Ustekinumab and vedolizumab as first-line biological therapy for inflammatory bowel disease. A multicenter study based on the ENEIDA registry. (30th January 2023)

Authors:
Calafat Sard, M; Pascual, I; Nos, P; Barrio, J; Gutiérrez, A; Martín-Arranz, M D; Ricart, E; Gomollón, F; Sierra Ausín, M; Huguet, J M; Guardiola, J; Vera, I; Varela, P; Iglesias, E; Garcia-Planella, E; de Castro, L; García Sepulcre, M F; Sicilia, B; Fernández-Salazar, L; Calvet, X
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i766
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

28. P638 Changes in the management of IBD patients since the onset of COVID-19 pandemic. A path towards the implementation of telemedicine in Spain?. (27th May 2021)

Authors:
Del Hoyo Francisco, J; Millán, M; Garrido-Marín, A; Nos, P; Barreiro-de Acosta, M; Bujanda, L; de la Portilla, F; Aguas, M
Journal:
Journal of Crohn's and colitis
Issue:
Volume 15(2021)Supplement 1
Page Start:
S572
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

29. P652 Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response. (30th January 2023)

Authors:
Mínguez, A; Bastida, G; Terol, I; Argumánez, V; Iborra, M; Aguas, M; Moret, I; Cerrillo, E; Garrido, A; Tortosa, L; Nos, P
Journal:
Journal of Crohn's and colitis
Issue:
Volume 17(2023)Supplement 1
Page Start:
i781
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

30. P654 Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry. (21st January 2022)

Authors:
González Muñoza, C; Calafat, M; Gisbert, J P; Iglesias, E; Minguez, M; Sicilia, B; Esteve, M; Gomollon, F; Calvet, X; Ricart, E; Carpio, D; Rivero, M; Lopez-Sanroman, A; Marquez, L; Nos, P; Cabriada, J L; Guardiola, J; Garcia-Sepulcre, M F; Garcia-Lopez, S; Lorente Poyatos, R
Journal:
Journal of Crohn's and colitis
Issue:
Volume 16(2022)Supplement 1
Page Start:
i567
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗